Current News November 05, 2013
Med BioGene Provides GeneFx® Lung Regulatory and Commercialization Update
August 30, 2013
Med BioGene Announces Discontinuance of Petition by Dissident Shareholders
August 22, 2013
Med BioGene Announces Settlement Agreement for the Dismissal of Litigation With Signal Genetics LLC and Respira Health LLC
June 03, 2013
Med BioGene Announces GeneFx® Lung ASCO Presentation and Provides Commercialization Update
February 25, 2013
Med BioGene Provides Update on Litigation With Signal Genetics LLC and Respira Health LLC
January 23, 2013
Precision Therapeutics and Med BioGene Announce Successful Completion of LungExpress Dx™ Clinical Studies; Precision Therapeutics Prepares for Commercial Launch
Latest News
|
Latest News
November 05, 2013
Med BioGene Provides GeneFx® Lung Regulatory and Commercialization Update
August 30, 2013
Med BioGene Announces Discontinuance of Petition by Dissident Shareholders
August 22, 2013
Med BioGene Announces Settlement Agreement for the Dismissal of Litigation With Signal Genetics LLC and Respira Health LLC
June 03, 2013
Med BioGene Announces GeneFx® Lung ASCO Presentation and Provides Commercialization Update
February 25, 2013
Med BioGene Provides Update on Litigation With Signal Genetics LLC and Respira Health LLC
January 23, 2013
Precision Therapeutics and Med BioGene Announce Successful Completion of LungExpress Dx™ Clinical Studies; Precision Therapeutics Prepares for Commercial Launch
|
|
© Copyright 2006 - Med BioGene Inc. - Legal Disclaimer